Women Fight Back against Birth Control Pill Misinformation
Reports of Yaz side effects continue to develop as the makers of Yaz, Yasmin and Ocella ready themselves for further litigation and more potential cases. Bayer Healthcare Pharmaceuticals, makers of Yasmin and Yaz, and Barr Pharmaceuticals, makers of the generic version Ocella have been barraged with allegations extending from downplaying the severity of side effects in their commercials to knowingly letting loose a serious and potentially deadly product on American women.
Among the other contestations impending on Yasmin, Yaz and Ocella birth control, the drugs also contain drospirenone, an element not in other oral contraceptives. The British Medical Journal issued studies in August 2009 recording a higher risk of venous blood clots in adult females taking drospirenone as opposed to those who received other oral contraceptives. In the same month, the Food & Drug Administration issued an uncorrelated advisory to Bayer Pharmaceuticals, makers of Yaz, for using low-quality batches of drospirenone from a plant in Germany. For the benefit of public interest and well-being, these studies have been made available free on the internet.
Any women that have been wounded as a result of taking Yaz, Yasmin or Ocella may be eligible to an award. Many lawyers and legal aid agencies such as thelegaladvocate.com now provide assistance to anyone experiencing side effects and health issues as a direct result of using Yasmin contraception. Now that more adult females across the country are coming forward and filing lawsuits, the legal system is moving closer to providing justice for those who were misinformed by the birth control manufacturers and possibly their doctors.











